Technology News and Research

RSS

Galectin strengthens cancer drug patent portfolio in Europe

Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".

15 Jun 2011

Intralytix obtains FDA, FSIS regulatory clearance for bacteriophage-based product against E. coli

Intralytix, Inc. announced today that it has completed regulatory clearance from both the Food and Drug Administration (FDA) and the United States Department of Agriculture's Food Safety and Inspection Service (FSIS) for its phage-based EcoShield food safety product, effective against E. coli O157:H7.

15 Jun 2011

California's rural elders more likely to be obese, physically inactive and food insecure

Despite living in the countryside, where open space is plentiful and there is often significant agricultural production, California's more than half a million rural elders are far more likely to be overweight or obese, physically inactive and food insecure than their suburban counterparts, according to a new policy brief from the UCLA Center for Health Policy Research.

15 Jun 2011

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.

15 Jun 2011

Precise method to determine age of bruises

Forensic scientists have to rely on their own subjective experience when asked to ascertain the age of contusions. Now, however, researchers in Norway have found a far more objective and precise method.

15 Jun 2011

Spinal Modulation completes Series D financing for $30 million

Spinal Modulation, Inc. announced today the completion of its $30 million Series D financing. Medtronic, Inc. joined existing investors DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson Development Corporation (JJDC), Kleiner Perkins Caufield & Byers, MedVenture Associates, and Raffles Venture Partners.

15 Jun 2011

GlycoVaxyn's Second Annual Science Day to highlight challenges of vaccine industry

GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.

15 Jun 2011

OncoSec Medical third quarter net loss increases to $491,000

OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, today reported financial results for the quarter ended April 30, 2011.

15 Jun 2011

QIAGEN to acquire Ipsogen

QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.

From QIAGEN Manchester Limited 15 Jun 2011

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Hanger Orthopedic Group, Inc. will deploy NextGen Ambulatory EHR and NextGen Practice Management.

15 Jun 2011

New York Times examines evolving role of social media in disease tracking efforts

The New York Times examines how social media is changing efforts to monitor the spread of diseases. According to the article, technology is democratizing the disease-hunting process, upsetting the old equilibrium by connecting people through channels effectively outside government control.

15 Jun 2011

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

HTX, a member of the Canadian Venture Capital Association, announced today it provided $750,000 in financing to Profound Medical Inc. through their Technology Assessment Program.

15 Jun 2011

APP announces $38 million expansion of New York manufacturing facility

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today a $38 million expansion of its Grand Island, New York manufacturing facility.

15 Jun 2011

BDC releases new technology to aid medical device industry with product design testing

Endovascular stents, stent grafts, and transcatheter heart valve (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices.

15 Jun 2011

Scientists use time-lapse technique to create lab model for ovarian cancer

Scientists at Harvard University have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer metastasis.

15 Jun 2011

New method could shorten healing times for dental implants

The technology used to replace lost teeth with titanium dental implants could be improved. By studying the surface structure of dental implants not only at micro level but also at nano level, researchers at the University of Gothenburg; Sweden, have come up with a method that could shorten the healing time for patients.

15 Jun 2011

NYU Langone implements biometric technology to identify patients

NYU Langone Medical Center announced today that it is the first medical center in the Northeast to use PatientSecure™ - a cutting-edge biometric technology - to identify patients. Utilizing near infrared light to map an image of the blood-flow pattern through the veins in a person's palm, the digital palm image is converted into a unique patient identifier that interfaces with the medical center's electronic health record system.

15 Jun 2011

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France, Nova23041.

15 Jun 2011

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

CONRAD and the South African Government's Technology Innovation Agency (TIA) today announced a license agreement that grants TIA the rights to manufacture and distribute Tenofovir1% gel in Africa.

15 Jun 2011

Pfizer, pSivida partner to develop latanoprost implant for ocular hypertension and glaucoma

Drug delivery company pSivida Corp today announced it amended and restated its Research and Development Agreement with Pfizer Inc. to focus solely on the development of a long-term, sustained-release implant to deliver latanoprost for patients with ocular hypertension and glaucoma.

15 Jun 2011

Technology News and Research

Galectin strengthens cancer drug patent portfolio in Europe

Intralytix obtains FDA, FSIS regulatory clearance for bacteriophage-based product against E. coli

California's rural elders more likely to be obese, physically inactive and food insecure

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Precise method to determine age of bruises

Spinal Modulation completes Series D financing for $30 million

GlycoVaxyn's Second Annual Science Day to highlight challenges of vaccine industry

OncoSec Medical third quarter net loss increases to $491,000

QIAGEN to acquire Ipsogen

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

New York Times examines evolving role of social media in disease tracking efforts

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

APP announces $38 million expansion of New York manufacturing facility

BDC releases new technology to aid medical device industry with product design testing

Scientists use time-lapse technique to create lab model for ovarian cancer

New method could shorten healing times for dental implants

NYU Langone implements biometric technology to identify patients

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

Pfizer, pSivida partner to develop latanoprost implant for ocular hypertension and glaucoma

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News